Tribunal partially allows appeal, upholds exclusion of patent income, remits ESOP expenditure, and overturns superannuation disallowance.

The Tribunal partly allowed the appeal, directing the Assessing Officer to re-evaluate certain claims. The exclusion of patent infringement income from export turnover for deduction under section 10B was upheld. However, the allocation of common corporate overheads based on cost accounting principles was accepted, leading to an increase in eligible profits. The disallowance of Employee Stock Option Plan (ESOP) expenditure was remitted for fresh consideration in line with a Special Bench decision. Claims for R&D expenditure were not pressed due to relief granted under section 154. The disallowance of superannuation contribution was overturned as it was found to be allowable under section 37.

---

---

Issues Involved:
1. Exclusion of patent infringement income from export turnover for deduction under section 10B.
2. Allocation of common corporate overheads for computing eligible profits under section 10B.
3. Disallowance of Employee Stock Option Plan (ESOP) expenditure.
4. Disallowance of claims under sections 35(2AB), 35(1)(i), and 35(1)(iv) for R&D expenditure.
5. Disallowance of superannuation contribution under section 37.

Issue-wise Detailed Analysis:

1. Exclusion of Patent Infringement Income from Export Turnover:
The assessee included Rs. 97,03,57,916/- received as patent infringement income in the export turnover for deduction under section 10B. The Assessing Officer (AO) excluded this amount, and the Commissioner of Income Tax (Appeals) [CIT(A)] upheld this exclusion. The Tribunal referenced its earlier decision in AY 2008-09, concluding that the income from settlement of patent infringement is not part of operational income and should be categorized as 'other income.' The Tribunal agreed with the AO and CIT(A), dismissing the ground.

2. Allocation of Common Corporate Overheads:
The AO allocated corporate overheads based on the turnover ratio, which reduced the eligible profits for deduction under section 10B. The assessee contended that the allocation should follow cost accounting principles. The Tribunal, referencing its earlier decision, found the assessee's method of allocation more rational and directed the AO to accept the assessee's allocation of corporate overheads. This ground was allowed.

3. Disallowance of ESOP Expenditure:
The AO disallowed Rs. 64,78,039/- claimed towards ESOP, considering it contingent and notional. The Tribunal referred to the Special Bench decision in the case of Biocon Ltd., which allowed ESOP discount as a deductible expenditure. The Tribunal remitted the issue to the AO to decide afresh in light of the Special Bench's decision. This ground was allowed for statistical purposes.

4. Disallowance of R&D Expenditure:
The assessee's claims under sections 35(2AB), 35(1)(i), and 35(1)(iv) were disallowed by the AO, which was upheld by the CIT(A). However, since relief was granted to the assessee by an order under section 154, these grounds were not pressed during the appeal.

5. Disallowance of Superannuation Contribution:
The AO disallowed Rs. 25,65,000/- claimed towards superannuation contribution for a director, stating it was covered under section 36(1)(iv) and not allowable under section 37. The CIT(A) upheld the disallowance. The Tribunal, referencing its earlier decision, found the expenditure allowable under section 37 since it was incurred for business purposes and tax was deducted at source. This ground was allowed.

Conclusion:
The appeal was partly allowed for statistical purposes, with specific directions provided to the AO for re-evaluation of certain claims. The Tribunal's decisions were consistent with earlier rulings and adhered to established accounting and tax principles.

---